In a Q&A interview, Dr. Dan Werb sits down to talk about the recent developments with DoseCheck, a groundbreaking drug checking technology funded by the U.S. National Institutes of Health (NIH). Led by Dr. Werb, this initiative aims to enhance DoseCheck’s capability in identifying and analyzing emerging street drugs quickly and effectively. Supported by Health Canada and the St. Michael’s Foundation, DoseCheck comprises a handheld device and smartphone app, empowering users to test drug samples on the spot and share results within their community. Dr. Werb discusses the significance of adaptive technology in combating the evolving drug landscape, highlighting DoseCheck’s potential to reduce overdose risks across Canada, especially in regions with high mortality rates like northern Ontario.

Read the full article here.